Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Rivastigmine
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 5, 6 💬
2Rivastigmine capsule
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
3Rivastigmine CF
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
4Rivastigmine luye transdermal patch- 9.5MG/24H
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
5Rivastigmine patch 9.5 CM2
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
6Rivastigmine transdermal patch
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 6, 13 💬
7Rivastigmine transdermal system
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
8Rivastigmine transdermal system 13.3 MG/24 H
(D02558)		1件: Rivastigmine2件: Rivastigmine tartrate (D02558),
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬